Opko Health Inc

Financials

総資産 2.47 B2.4 B2.17 B2.01 B2.2 B1.93 B 負債合計 801.51 M714.59 M605.61 M622.48 M834.76 M663.99 M 純資産合計 1.67 B1.69 B1.56 B1.39 B1.37 B1.27 B 負債および純資産合計 2.47 B2.4 B2.17 B2.01 B2.2 B1.93 B 有利子負債合計 224.44 M190.19 M258.87 M12.55 M6.07 M347.92 M 純負債 203.65 M120.99 M142 M-21.02 M-362.08 M-314.42 M

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK

Financials

Opko Health Inc

ニュース

OPKO Health: The Waiting Game Continues (NASDAQ:OPK)

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates

【決算速報】オプコ・ヘルス、売上高は予想を上回り、利益は予想を上回る結果に

Opko Health earnings beat by $0.03, revenue topped estimates

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

H.C. ウェインライトがOpko Healthの株式評価を「買い」で再確認

Opko Health stock rating reiterated at Buy by H.C. Wainwright

OPKOとEnteraが副甲状腺機能低下症治療のための経口PTH開発で提携拡大